v3.25.2
Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders’ equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Operating Partnership Unitholders’ Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2023     21,960,211        
Beginning balance at Dec. 31, 2023 $ 301,625 $ 243,562 $ 219 $ 287,268 $ 4,621 $ (48,546) $ 58,063
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net proceeds from sale of common stock (in shares)     576,087        
Net proceeds from sale of common stock 7,867 7,867 $ 6 7,861      
Issuance of operating partnership units in connection with acquisition transactions 5,788           5,788
Issuance and amortization of equity-based compensation, net of forfeitures (in shares)     120,941        
Issuance and amortization of equity-based compensation, net of forfeitures 2,113 1,148 $ 1 1,147     965
Issuance and amortization under the employee stock purchase plan ("ESPP") (in shares)     5,137        
Issuance and amortization under the employee stock purchase plan ("ESPP") 77 77   77      
Restricted stock withholdings (in shares)     (27,919)        
Restricted stock withholdings (396) (396)   (396)      
Dividends and distributions (6,859) (5,520)       (5,520) (1,339)
Unrealized (loss) gain on derivative instruments 2,819 2,267     2,267   552
Net income 256 206       206 50
Reallocation of non-controlling interest 0 (1,079)   (1,079)     1,079
Ending balance (in shares) at Mar. 31, 2024     22,634,457        
Ending balance at Mar. 31, 2024 313,290 248,132 $ 226 294,878 6,888 (53,860) 65,158
Beginning balance (in shares) at Dec. 31, 2023     21,960,211        
Beginning balance at Dec. 31, 2023 301,625 243,562 $ 219 287,268 4,621 (48,546) 58,063
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized (loss) gain on derivative instruments 2,833            
Net income 1,288            
Ending balance (in shares) at Jun. 30, 2024     22,744,912        
Ending balance at Jun. 30, 2024 309,532 245,480 $ 228 296,886 6,899 (58,533) 64,052
Beginning balance (in shares) at Mar. 31, 2024     22,634,457        
Beginning balance at Mar. 31, 2024 313,290 248,132 $ 226 294,878 6,888 (53,860) 65,158
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net proceeds from sale of common stock (in shares)     57,993        
Net proceeds from sale of common stock 685 685 $ 1 684      
Shares issued upon redemption of operating partnership units (in shares)     52,778        
Shares issued upon redemption of operating partnership units 0 862 $ 1 861     (862)
Issuance and amortization of equity-based compensation, net of forfeitures (in shares)     (316)        
Issuance and amortization of equity-based compensation, net of forfeitures 1,433 722   722     711
Issuance and amortization under the employee stock purchase plan ("ESPP") 6 6   6      
Dividends and distributions (6,928) (5,490)       (5,490) (1,438)
Unrealized (loss) gain on derivative instruments 14 11     11   3
Net income 1,032 817       817 215
Reallocation of non-controlling interest 0 (265)   (265)     265
Ending balance (in shares) at Jun. 30, 2024     22,744,912        
Ending balance at Jun. 30, 2024 309,532 245,480 $ 228 296,886 6,899 (58,533) 64,052
Beginning balance (in shares) at Dec. 31, 2024     23,521,693        
Beginning balance at Dec. 31, 2024 317,498 251,285 $ 235 310,031 5,230 (64,211) 66,213
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net proceeds from sale of common stock (in shares)     139,626        
Net proceeds from sale of common stock 1,820 1,820 $ 1 1,819      
Issuance of operating partnership units in connection with acquisition transactions 1,026           1,026
Issuance and amortization of equity-based compensation, net of forfeitures (in shares)     77,623        
Issuance and amortization of equity-based compensation, net of forfeitures 2,332 818 $ 1 817     1,514
Issuance and amortization under the employee stock purchase plan ("ESPP") (in shares)     5,527        
Issuance and amortization under the employee stock purchase plan ("ESPP") 77 77   77      
Restricted stock withholdings (in shares)     (21,092)        
Restricted stock withholdings (277) (277)   (277)      
Dividends and distributions (7,382) (5,761)       (5,761) (1,621)
Unrealized (loss) gain on derivative instruments (2,844) (2,229)     (2,229)   (615)
Net income 2,655 2,082       2,082 573
Reallocation of non-controlling interest 0 (2,336)   (2,336)     2,336
Ending balance (in shares) at Mar. 31, 2025     23,723,377        
Ending balance at Mar. 31, 2025 314,905 245,479 $ 237 310,131 3,001 (67,890) 69,426
Beginning balance (in shares) at Dec. 31, 2024     23,521,693        
Beginning balance at Dec. 31, 2024 317,498 251,285 $ 235 310,031 5,230 (64,211) 66,213
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized (loss) gain on derivative instruments (4,469)            
Net income 7,327            
Ending balance (in shares) at Jun. 30, 2025     24,264,403        
Ending balance at Jun. 30, 2025 324,554 250,802 $ 242 318,914 1,744 (70,098) 73,752
Beginning balance (in shares) at Mar. 31, 2025     23,723,377        
Beginning balance at Mar. 31, 2025 314,905 245,479 $ 237 310,131 3,001 (67,890) 69,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net proceeds from sale of common stock (in shares)     529,828        
Net proceeds from sale of common stock 7,561 7,561 $ 5 7,556      
Issuance of operating partnership units in connection with acquisition transactions 5,005           5,005
Shares issued upon redemption of operating partnership units (in shares)     11,198        
Shares issued upon redemption of operating partnership units 0 157   157     (157)
Issuance and amortization of equity-based compensation, net of forfeitures 1,570 700   700     870
Issuance and amortization under the employee stock purchase plan ("ESPP") 19 19   19      
Dividends and distributions (7,553) (5,822)       (5,822) (1,731)
Unrealized (loss) gain on derivative instruments (1,625) (1,257)     (1,257)   (368)
Net income 4,672 3,614       3,614 1,058
Reallocation of non-controlling interest 0 351   351     (351)
Ending balance (in shares) at Jun. 30, 2025     24,264,403        
Ending balance at Jun. 30, 2025 $ 324,554 $ 250,802 $ 242 $ 318,914 $ 1,744 $ (70,098) $ 73,752